Toggle Offcanvas
...
 
Bendamustine Tenders

Bendamustine Tenders

View Bendamustine tenders, RFPs and contracts. Bid on readily available Bendamustine tenders with the best and most comprehensive tendering platform, since 2002.
Bendamustine is a chemotherapy drug used in treating non Hodgkin’s lymphoma and chronic lymphocytic leukemia. It works by damaging DNA, leading to cancer cell death. Bendamustine is often used in combination with other cancer treatments.

Bidding for Bendamustine tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Bendamustine.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Bendamustine market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Bendamustine tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

5 Live Notices for Bendamustine Tenders

Showing 1 to 5

Delivery Of Medicinal Products
country Poland
posting date15 Jul 2025
deadline19 Aug 2025
L01XA03 Oxaliplatin concentrate for solution for infusion 100 mg vial 96
country North Macedonia
posting date02 Jul 2025
deadline28 Jul 2025
Dk 021: 2015: Dk 021: 2015 - 33600000-6 Pharmaceutical Products (Dk 021: 2015: 33650000-1 - General Anti -Infectious Agents For Systemic Use, Vaccines, Antineoplastic Agents And Immunomodulators) Bendamustin, Liophysis, Liophysis (Powder). (Powder), 2.5 Mg,… More
country Ukraine
posting date23 Jul 2025
deadline07 Aug 2025
Bendamustine (100 Mg In Vial, Powder For Preparation Of Concentrate For Infusion Solution)
country Ukraine
posting date21 Jul 2025
deadline05 Aug 2025
Bendamustine Inj 100 Mg Vial
country India
posting date16 Jul 2025
deadline19 Aug 2025

Share Share this page